Year: 2021

The company is ready to “Build Back Smarter” CENTREVILLE, Va., Nov. 30, 2021 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) applauds the signing of the Bipartisan Infrastructure Deal (Infrastructure Investment and Jobs Act), citing its importance to the future of infrastructure and economic growth in the United States. In 2021, the American Society of Civil Engineers gave the state of U.S. infrastructure a “C-” grade – a small improvement from its previous “D” score – something the Infrastructure Bill hopes to address. Infrastructure is essential to the safe and efficient movement of people and goods across the country; the storage, transmission, treatment and distribution of water; the collection, treatment and discharge or reuse of wastewater; the generation, transmission and distribution of electrical power; healthcare;...

The partnership will focus on the licensing, supply, and expected commercialization of Avicanna’s cannabinoid-based drug candidate Trunerox™, in Argentina in the second half 2022 TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has entered into a partnership with an established Argentine pharmaceutical company to register and commercialize Avicanna’s proprietary cannabinoid-based pharmaceutical preparations through the licensing of its intellectual property and supply of its active pharmaceutical ingredients (“API”). Through the partnership Avicanna will provide a...

Designed for rapid “plug and play” programming and stockpiling against emerging infectious agents and viral mutations Emergence of Omicron and other COVID-19 variants underscores the need for a rapid, safe, and effective response to potential biological threats RapidVax Presentation at the 2021 World Vaccine & Immunotherapy Congress West Coast and World Antiviral Congress 2021 DURHAM, N.C., Nov. 30, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today unveiled its new RapidVax® cellular vaccine platform at the 2021 World Antiviral Congress. RapidVax is designed as a rapid programmable vaccine to target a comprehensive range of emerging biological threats. Heat is showcasing a poster...

Mr. Klemmick Previously Worked with John Keller and First Solar and on Tellurium prospects in North America and Europe VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) — First Tellurium Corp. (CSE: FTEL) (the “Company” or “First Tellurium”), announces George Klemmick has joined our team. With over 32 years in the field working as a senior geologist, project and exploration manager he brings a wealth of hands-on experience to our project. Mr. Klemmick, who has previously worked with John Keller and First Solar and on the Klondike tellurium property, will assist in management of the project. Mr. Klemmick is a Certified Professional Geologist and is a Qualified Person (QP) under 43-101 rules. “There has been a lot of exploration excitement recently around lithium,” stated George Klemmick “but the global market remains relatively...

TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC; Frankfurt: 4Y7 or WKN: A0M2QX) is pleased to announce it has completed airborne Magnetic-Spectrometer and high resolution Magnetic-Time-Domain Electromagnetic (MAG-SPEC & MAG-TDEM) surveys over the Good Hope Niobium and the Pic River PGE-Cu-Ni Projects located along the north shore of Lake Superior in the Marathon area. Prospectair Geosurveys Inc. conducted the surveys. Plato Gold Corp. is also pleased to announce it has been granted exploration permits (3-year term) from the Ontario Ministry of Northern Development, Mines, Natural Resources and Forestry for the following 4 Projects:  Good Hope Niobium Project Pic River Palladium Project Marriott Gold Project Holloway Gold ProjectThe Good Hope Niobium Project was optioned from 2020 PDAC Prospector...

PETAH TIKVA, Israel, Nov. 30, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today a follow-on order of over $5M from a Tier-1 US global military terminal provider for Solid State Power Amplifiers (SSPAs) for satellite communication (SATCOM) terminals sold to militaries throughout the world. Further contract expansion for Wavestream MicroStream SSPAs is expected in the near future. Gilat’s fully-owned subsidiary, Wavestream, will provide tightly integrated MicroStream frequency conversion/amplifier units. Wavestream’s MicroStream Ka-band SSPAs were chosen because they efficiently meet the exacting SWaP requirements most essential for tactical and expeditionary military users. “We are proud...

Aktia Bank PlcPress release30 November 2021 at 2.00 p.m. Aktia to become partner in Alexander Corporate Finance Aktia Bank Plc and Alexander Corporate Finance Oy (“ACF”) have agreed on an arrangement, which will result in Aktia owning 20% of ACF’s shares. The share subscription is scheduled to take place in January 2022 and is conditional on the approval of the Financial Supervisory Authority. With the issue, the new name of Alexander Corporate Finance will be Aktia Alexander Corporate Finance Oy. “In the future, the arrangement will provide Aktia’s customers access to investment banking, such as financial advice on mergers and acquisitions, initial public offerings and valuation services. Small and medium-sized enterprises constitute the core of both Aktia’s and ACF’s strategies, which makes us particularly compatible partners,”...

Silence Therapeutics Begins Exclusive Nasdaq Trading 30 November 2021 LONDON, Silence Therapeutics plc, Nasdaq:SLN (“Silence” or “the Company“), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that the cancellation of admission of its ordinary shares of nominal value £0.05 each (the “Ordinary Shares”) to trading on AIM (the “AIM Delisting”) was effective from 7:00 a.m. (London time) today. Silence’s American Depositary Shares, each representing three Ordinary Shares (the “ADSs”), are now listed and only tradeable on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol SLN. Mark Rothera, President and Chief Executive Officer of Silence, said: “Listing solely...